Why RMP for Oncology Studies
Complex oncology, delivered through an integrated network
Supporting Oncology, Precision Medicine, Radiopharmaceutical, and Biomarker-Driven Clinical Trials Through an Integrated Network of Investigators, Research Sites, and Biospecimen Collection Partners.
As oncology research continues to evolve toward targeted therapies, radiopharmaceuticals, and biomarker-driven treatment approaches, Sponsors require research partners capable of managing increasingly complex protocols.
RMP provides access to experienced investigators, integrated clinical sites, biospecimen collection capabilities, and centralized operational oversight designed to support oncology studies from feasibility through closeout.
Oncology Clinical Trial Infrastructure
Hematology-Oncology
Support for hematologic programs alongside medical oncology workflows within the network.
Radiation Oncology
Infrastructure aligned to radiation-oncology studies requiring specialized treatment coordination.
Medical Oncology
Clinical research support across medical oncology indications and evolving treatment pathways.
Precision Medicine Programs
Programs that depend on molecular insight, specialty collaboration, and stratified enrollment.
Biomarker-Driven Studies
Study models that require biomarker identification, screening alignment, and targeted recruitment.
Radiopharmaceutical Research Readiness
Operational readiness for complex protocols involving radiopharmaceutical and theranostic approaches.
Biospecimen Collection and Laboratory Partnerships
Blood Collection
PBMC Processing
Genomic Testing
Chain of Custody Management
Tissue Collection
Biomarker Analysis
Sample Processing & Storage
Protocol-Specific Laboratory Workflows
Oncology Investigators
This model provides access to established patient populations, engaged investigators, and existing clinical infrastructure, creating opportunities for faster recruitment and stronger patient retention.
Therapeutic Experience
Solid Tumors
Immuno-Oncology
Hematologic Malignancies
Precision Medicine
Radiation Oncology
Biomarker Studies
Targeted Therapies
Why Sponsors Choose RMP
Access to Oncology Patients
Reach oncology and related patient populations through integrated clinical practices.
Integrated Clinical Workflows
Align research activities with existing care pathways to support enrollment and retention.
Biospecimen Collection Support
Coordinate sample collection and laboratory workflows required by complex oncology protocols.
Centralized Quality Oversight
Maintain consistency across sites with centralized quality, training, and operational support.
Multi-Site Scalability
Scale oncology programs across participating sites under one operational partner.
Experienced Investigators
Engage investigators with oncology, hematology, and radiation-oncology research experience.